We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENFY
6926
DELISTED
Enlightify Inc
ENFY
$0 ﹤0.01%
1
-120
-99% -$1.88K
ENFY
6927
PUT
DELISTED
Enlightify Inc
ENFY
-92
Closed -$1K
QVCGA
6928
CALL
DELISTED
QVC Group Inc Series A
QVCGA
-261
Closed -$253K
VIVS
6929
CALL
VivoSim Labs
VIVS
$1.21M
-58
Closed -$47K
VOXX
6930
DELISTED
VOXX International Corporation Class A
VOXX
$0 ﹤0.01%
61
SYRS
6931
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$0 ﹤0.01%
2
-1
-33% -$122
AE
6932
DELISTED
Adams Resources & Energy Inc
AE
$0 ﹤0.01%
+10
New +$385
CNSL
6933
CALL
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
-1,100
Closed -$30K
CNSL
6934
PUT
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
-300
Closed -$8K
CHUY
6935
CALL
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
-30,000
Closed -$974K
EGRX
6936
PUT
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
-146,000
Closed -$11.6M
ALIM
6937
DELISTED
Alimera Sciences
ALIM
$0 ﹤0.01%
6
AAMC
6938
DELISTED
Altisource Asset Management Corp
AAMC
-3
Closed
TWOU
6939
CALL
DELISTED
2U Inc
TWOU
-460
Closed -$416K
WIRE
6940
CALL
DELISTED
Encore Wire Corp
WIRE
-1,000
Closed -$43K
ERF
6941
DELISTED
Enerplus Corporation
ERF
-11,918
Closed -$105K
ALPN
6942
DELISTED
Alpine Immune Sciences Inc
ALPN
-1,000
Closed -$9K
NURO
6943
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
-2
Closed -$1K
YTEN
6944
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
AAU
6945
DELISTED
Almaden Minerals Ltd
AAU
$0 ﹤0.01%
+56
New +$61
MTBL
6946
PUT
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
-8,200
Closed -$20K
CCLP
6947
DELISTED
CSI Compressco LP
CCLP
$0 ﹤0.01%
+10
New +$107
CSTR
6948
DELISTED
CapStar Financial Holdings, Inc
CSTR
$0 ﹤0.01%
14
+9
+180% +$176
BPTH
6949
DELISTED
Bio-Path Holdings Inc
BPTH
0
SALM
6950
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$0 ﹤0.01%
57
-116
-67% -$791

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.